Chronic Malignancies Working Party (CMWP)
Lymphoma Working Party (LWP)
Type d'étude:
Numéro de l'étude:
2013-N-02
Type de traitement à base de cellules souches:
Maladies:
Chronic Lymphocytic Leukaemia (CLL)
Non-Hodgkin’s Lymphoma (NHL)
Titre court:
BCRi survey
Objectif principal:
OBJECTIVE: To assess safety and efficacy of HSCT after previous exposure to BCRi/BCL2a
Principaux critères d'inclusion:
First allogeneic HSCT, diagnosis of MCL, CLL, FL, WM or DLBCL, age over 18 years at transplant, allografted 2013-March 2015, donor SIB or well or partially matched unrelated, any conditioning regimen, documented pre-transplant exposure to BCRi/BCL2a
Pays:
Investigateur principal:
Peter Dreger, Johannes Schetelig
Coordinateur EBMT de l'étude:
Hervé Finel